| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: ethanol; Genotype: SKH1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
Treatment: estradiol; Genotype: SKH1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: estradiol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: ethanol; Genotype: inducible version of CEBPA (C/EBPalpha-ER); |
Permissive
Robust
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: ethanol; Genotype: Kkasumi1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
Kasumi-1 (acute myeloblastic leukemia) |
Treatment: estradiol; Genotype: Kkasumi1; |
Permissive
|
Homo sapiens |
GSE102697
...
|
MA0019.1
...
|
| CEBPA |
MA9 transformed mouse leukemia |
Treatment: none Genotype: MLL-AF9 fusion |
Permissive
Robust
|
Mus musculus |
GSE100758
...
|
MA0019.1
...
|
| CEBPA |
MA9 transformed mouse leukemia |
Treatment: LSD1 inhibitor GSK-LSD1 Genotype: MLL-AF9 fusion |
Permissive
Robust
|
Mus musculus |
GSE100758
...
|
MA0019.1
...
|
| CEBPA |
HMM (HOXA9 transormed myeloblasts) |
Genotype: HOXA9/MEIS1-transformed Treament: culture conditions Myeloid (10ng/mL IL3) + 100nM 4OHT for 25 -31 days Source: in- bone marrow |
Permissive
Robust
|
Mus musculus |
GSE103446
...
|
MA0019.1
...
|
| CEBPA |
HMM (HOXA9 transormed myeloblasts) |
Genotype: HOXA9 inactivation Treatment: culture conditions Myeloid (10ng/mL IL3) + 4OHT for 25 -31 days wash off Source: Lin- bone marrow |
Permissive
Robust
|
Mus musculus |
GSE103446
...
|
MA0019.1
...
|
Showing 10 records in page 52
from 658 pages